Background and purpose: To compare two in-beam monitoring devices for prostate radiotherapy: intraprostatic electromagnetic transmitters (EM-T) (RayPilot ® , Micropos Medical) and ultrasound imaging using transperineal probe (TP-US) (Clarity ® , Elekta) used concomitantly on phantom and on patients. Materials and methods: The phantom study evaluated accuracy in presence of known translations and rotations. Then intra-fraction motions were analyzed for 10 prostate cancer patients implanted with the EM-T 8 days before the simulation CT (171 sessions). The percent time in which the differences between the systems were 1 to 5mm were scored for each direction. Results: Experiments on phantom confirmed no interference between the systems and showed deviations of less than 0.5mm when translations were applied progressively. In presence of rotations (5-15°), both systems displayed systematic shifts up to 6.9 and 3.8mm for the TP-US and the EM-T, respectively. Absolute mean differences between displacements observed on patients with EM-T and TP-US were ≤0.55mm in all directions except for one patient (≤1.77mm). With an exception for this patient, a strong correlation was found in left-right direction: differences >2mm were monitored less than 0.22% of the time (mean acquisition time:164 minutes) and never exceeded 5 seconds. Maximum differences were observed in supero-inferior direction with differences>2mm monitored more than 6.5% of the time for 3 patients. Large prostate rotations, the presence of gas and EM-T location in the prostate may explain important differences. Conclusion: Apart from the systematic shifts induced by the rotations, the two systems were correlated and represent feasible solutions for monitoring prostate cancer treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.